Research Advances in EEG, Exercise, and Gut Health for Dementia Risk Reduction

What Happens Next

• →EEG equipment manufacturers and neurodiagnostic service providers see increased inquiry volume and pilot program proposals from hospital systems and research institutions exploring brain age index screening.
• →Fitness technology companies and senior-focused wellness platforms accelerate development of exercise programs marketed around cognitive health, with venture capital flowing into wearable devices that track intensity metrics relevant to dementia prevention.
• →Pharmaceutical and nutraceutical firms expand R&D pipelines targeting the gut-brain axis, with early-stage clinical trials and microbiome-based supplement lines positioned around cognitive decline prevention.

Near-term: Neurodiagnostic companies and EEG equipment manufacturers receive increased interest from research institutions and health systems evaluating brain age index as a screening tool, driving a 10-20% rise in pilot program contracts. Long-term: The gut-brain axis becomes a major pharmaceutical and nutraceutical R&D category, with multiple microbiome-based therapeutics entering Phase II/III trials and regulatory frameworks adapting to classify cognitive-health probiotics.